Skip to Content

Join the 'Mycophenolate Mofetil' group to help and get support from people like you.

Mycophenolate Mofetil News

Kidney Woes Tied to Raised Cancer Risk, Study Finds

Posted 12 Nov 2015 by Drugs.com

THURSDAY, Nov. 12, 2015 – Kidney failure and having a kidney transplant may increase the risk for certain types of cancer, a new study suggests. Poor kidney function and immune system-suppressing drugs may be behind this increased risk, according to Elizabeth Yanik, of the U.S. National Cancer Institute, and colleagues. For the study, published in the Nov. 12 online edition of the Journal of the ...

Drug Combo Helps Lupus-Related Kidney Condition

Posted 10 Nov 2014 by Drugs.com

MONDAY, Nov. 10, 2014 – A combination of drugs may offer a better way to combat a serious kidney complication that commonly affects people with lupus, a new study from China suggests. In a trial of more than 300 Chinese patients with the condition, known as lupus nephritis, those who were given a trio of powerful drugs were more likely to see a complete remission. After six months, 46 percent ...

Kidney Transplant Rejection Drugs Tied to Pregnancy Risks in Study

Posted 23 Oct 2013 by Drugs.com

WEDNESDAY, Oct. 23 – Drugs meant to reduce the risk of organ rejection may increase the risk of miscarriage and birth defects when taken by female kidney transplant patients, according to a new study. The drugs – called mycophenolic acid products – reduce the risk of organ rejection by suppressing the immune system. The study included 163 female transplant patients who discontinued ...

New Guidelines Issued for Severe Lupus

Posted 3 May 2012 by Drugs.com

THURSDAY, May 3 – When diagnosed with lupus, one in three people already has kidney inflammation, and during the first 10 years with the disease as many as 60 percent of patients will have some kidney problems. Because kidney inflammation (also called lupus nephritis) is so common in people with lupus, the American College of Rheumatology has issued new guidelines for the screening and ...

Newer Drug Seems Better at Controlling Lupus Kidney Complication

Posted 16 Nov 2011 by Drugs.com

WEDNESDAY, Nov. 16 – A newer immune-suppressing drug called mycophenolate mofetil (CellCept) is better at controlling a serious kidney complication from lupus than another commonly used therapy, a new study suggests. People taking mycophenolate were about half as likely to progress to treatment failure as were people taking azathioprine (Imuran), according to the researchers. "This study was ...

Ask a Question

Further Information

Related Condition Support Groups

Nephrotic Syndrome, Organ Transplant - Rejection Prophylaxis, Autoimmune Hepatitis, Bullous Pemphigoid, Graft-versus-host disease, Ulcerative Colitis, Systemic Lupus Erythematosus, Rheumatoid Arthritis, Pulmonary Fibrosis, view more... Psoriatic Arthritis, Pemphigus, Pemphigoid, Myasthenia Gravis, Multiple Sclerosis, Linear IgA Disease, Inflammatory Bowel Disease, High Cholesterol, Evan's Syndrome, Dermatomyositis, Crohn's Disease, Cogan's Syndrome, Uveitis

Related Drug Support Groups

CellCept

Mycophenolate Mofetil Patient Information at Drugs.com